The actual impact of transarterial chemoembolization before liver transplantation (LT) for hepatocellular carcinoma (HCC) on patient survival and HCC recurrence is not known. Between 1985 and 1998, 479 patients with HCC in 14 French centers were evaluated for LT. Among these 479 patients, this case-
765 CHANGES IN STEM CELL MARKER EXPRESSION AFTER CHEMOEMBOLIZATION AND RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION
β Scribed by Z. Zeng; J.Y. Ren; M. Neil; J. Zhao; G. Chaturvedi; Y.P. Yang; S.A. Weinman
- Book ID
- 117380975
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 79 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background and Objectives Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) remains a major cause of postβLT death. However, currently there is still lacking the markers to reliably predict recurrence. This study was undertaken to evaluate the association
Matrix metalloproteinases (MMPs) are known to play an important role in cell migration during cancer invasion by degrading extracellular matrix proteins. This study aimed to determine the role of MMP-9 in hepatocellular carcinoma (HCC) carcinogenesis. Eighty-nine cases who underwent liver transplant